Want to join the conversation?
Compass Point analyst Bill Billingsley questions on the expense ratio, excluding acquisitions costs, continuing to be down YoverY. CEO Gabriel Tirador said that $MCY is actively managing its expenses and trying to keep it in line. As earned premiums are going up, the company has been holding the line on the OpEx so that the ratios improve.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.